Which statement best describes drug safety in porphyria cutanea tarda?

Which statement best describes drug safety in porphyria cutanea tarda?

• A. Only regional techniques are avoided due to neurotoxicity
• B. Propofol, neuromuscular blockers, inhalation agents, and opioids are safe
• C. Sodium pentothal is safe but others are not
• D. All antibiotics should be avoided

Answer: (B)

Drug safety in porphyria cutanea tarda centers on avoiding drugs that trigger hepatic porphyrin production while using agents that have established safety in porphyrias. In porphyria cutanea tarda, the risk comes from drugs that induce hepatic ALA synthase and worsen porphyrin buildup, but many common anesthetic drugs do not have this effect and are considered safe. Propofol is favored for induction and maintenance because it does not meaningfully stimulate hepatic heme synthesis and is widely regarded as safe in porphyrias. Nondepolarizing neuromuscular blockers are also generally safe in this condition since they do not provoke porphyrin production. Among inhaled anesthetics, agents used routinely in modern practice are viewed as safe options in porphyrias, and opioids such as fentanyl provide analgesia without triggering porphyrin pathways. The other statements misrepresent safety. Regional anesthesia is not contraindicated purely due to porphyria; the issue is not a neurotoxicity concern with regional techniques in this context. Thiopental (sodium pentothal) is not considered safe in porphyrias, and it is not correct to claim otherwise. Finally, not all antibiotics must be avoided—only specific ones with porphyrinogenic potential are problematic, while many antibiotics can be used safely.

Drug safety in porphyria cutanea tarda centers on avoiding drugs that trigger hepatic porphyrin production while using agents that have established safety in porphyrias. In porphyria cutanea tarda, the risk comes from drugs that induce hepatic ALA synthase and worsen porphyrin buildup, but many common anesthetic drugs do not have this effect and are considered safe.

Propofol is favored for induction and maintenance because it does not meaningfully stimulate hepatic heme synthesis and is widely regarded as safe in porphyrias. Nondepolarizing neuromuscular blockers are also generally safe in this condition since they do not provoke porphyrin production. Among inhaled anesthetics, agents used routinely in modern practice are viewed as safe options in porphyrias, and opioids such as fentanyl provide analgesia without triggering porphyrin pathways.

The other statements misrepresent safety. Regional anesthesia is not contraindicated purely due to porphyria; the issue is not a neurotoxicity concern with regional techniques in this context. Thiopental (sodium pentothal) is not considered safe in porphyrias, and it is not correct to claim otherwise. Finally, not all antibiotics must be avoided—only specific ones with porphyrinogenic potential are problematic, while many antibiotics can be used safely.